Mioclonías inducidas por salbutamol

Montoya-Giraldo, María Alejandra; Montoya, Dayana Vanessa; Atehortúa, David Alexander; Buendía, Jefferson Antonio; Zuluaga, Andrés Felipe.
Biomédica (Bogotá) ; 38(3): 303-307, jul.-set. 2018.
Artículo en Español | LILACS | ID: biblio-973983

Documentos relacionados

  1. Myoclonus induced by salbutamol: A case report
  2. Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.
  3. Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
  4. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
  5. Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with ß<sub>2</sub> -agonists.
  6. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
  7. Association Between Instant Coffee Consumption and the Development of Chronic Obstructive Pulmonary Disease: Results From a Community-Based Prospective Cohort.
  8. COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.
  9. The effect of indacaterol during an acute exacerbation of COPD.
  10. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.